CompletedNCT04738695

SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sciensano
Principal Investigator
An De Sutter, Prof. Dr.
University Ghent
Intervention
Point-of-care rapid anti-SARS-CoV-2 antibody test (Orient Gene Biotech) and Dry Blood Spot collection (Euroimmun)(diagnostic_test)
Enrollment
3008 target
Eligibility
18 years · All sexes
Timeline
20212022

Study locations (1)

Collaborators

KU Leuven · University of Liege · Universiteit Antwerpen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04738695 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials